Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study

AIMS: Cardiac resynchronisation therapy (CRT) is effective treatment for selected patients with heart failure (HF) but has ~30% non-response rate. We evaluated whether specific biomarkers can predict outcome. METHODS: A prospective single-centre pilot study of consecutive unselected patients undergo...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Open Heart
Prif Awduron: McAloon, Christopher J, Barwari, Temo, Hu, Jimiao, Hamborg, Thomas, Nevill, Alan, Hyndman, Samantha, Ansell, Valerie, Musa, Anntoniette, Jones, Julie, Goodby, Julie, Banerjee, Prithwish, O’Hare, Paul, Mayr, Manuel, Randeva, Harpal, Osman, Faizel
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2018
Pynciau:
Heart Failure and Cardiomyopathies
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196945/
https://ncbi.nlm.nih.gov/pubmed/30364565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2018-000899
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg